메뉴 건너뛰기




Volumn 32, Issue 25, 2013, Pages 3028-3038

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas

Author keywords

Evi1; malignant histiocytosis; murine BMT model; myelomonocytic leukemia; NRas; retroviral vector

Indexed keywords

ASPARTIC ACID; EVI1 PROTEIN; GLYCINE; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PRDM16 PROTEIN; PROTEIN KINASE B; PROTEIN N RAS; RAS PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

EID: 84879416050     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.329     Document Type: Article
Times cited : (7)

References (67)
  • 1
    • 0025010979 scopus 로고
    • The GTPase superfamily: A conserved switch for diverse cell functions
    • Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990; 348: 125-132.
    • (1990) Nature , vol.348 , pp. 125-132
    • Bourne, H.R.1    Sanders, D.A.2    McCormick, F.3
  • 2
    • 0037264633 scopus 로고    scopus 로고
    • Targeting RAS signalling pathways in cancer therapy
    • Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003; 3: 11-22
    • (2003) Nat Rev Cancer , vol.3 , pp. 11-22
    • Downward, J.1
  • 3
    • 84879415832 scopus 로고    scopus 로고
    • COSMIC database
    • COSMIC database http://www.sanger.ac.uk/genetics/CGP/cosmic/.
  • 5
    • 77956237515 scopus 로고    scopus 로고
    • Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1
    • Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858-3865.
    • (2010) J Clin Oncol , vol.28 , pp. 3858-3865
    • Kohlmann, A.1    Grossmann, V.2    Klein, H.U.3    Schindela, S.4    Weiss, T.5    Kazak, B.6
  • 6
    • 43449083229 scopus 로고    scopus 로고
    • Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia
    • Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008; 141: 567-575.
    • (2008) Br J Haematol , vol.141 , pp. 567-575
    • Koike, K.1    Matsuda, K.2
  • 7
    • 0034284027 scopus 로고    scopus 로고
    • Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies?
    • Reuter CW, Morgan MA, Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood 2000; 96: 1655-1669.
    • (2000) Blood , vol.96 , pp. 1655-1669
    • Reuter, C.W.1    Morgan, M.A.2    Bergmann, L.3
  • 8
    • 0029966854 scopus 로고    scopus 로고
    • The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomo-nocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways
    • Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomo-nocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996; 93: 14845-14850.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 14845-14850
    • Carroll, M.1    Tomasson, M.H.2    Barker, G.F.3    Golub, T.R.4    Gilliland, D.G.5
  • 9
    • 70349249988 scopus 로고    scopus 로고
    • Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
    • Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009; 114: 1859-1863.
    • (2009) Blood , vol.114 , pp. 1859-1863
    • Loh, M.L.1    Sakai, D.S.2    Flotho, C.3    Kang, M.4    Fliegauf, M.5    Archambeault, S.6
  • 10
    • 84984935016 scopus 로고    scopus 로고
    • Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
    • Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 2010; 42: 794-800.
    • (2010) Nat Genet , vol.42 , pp. 794-800
    • Niemeyer, C.M.1    Kang, M.W.2    Shin, D.H.3    Furlan, I.4    Erlacher, M.5    Bunin, N.J.6
  • 11
    • 76549092856 scopus 로고    scopus 로고
    • Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1
    • Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Stary J et al. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica 2010; 95: 320-323.
    • (2010) Haematologica , vol.95 , pp. 320-323
    • Steinemann, D.1    Arning, L.2    Praulich, I.3    Stuhrmann, M.4    Hasle, H.5    Stary, J.6
  • 12
    • 0030843626 scopus 로고    scopus 로고
    • Juvenile myelomonocytic leukemia
    • Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488.
    • (1997) Blood , vol.90 , pp. 479-488
    • Arico, M.1    Biondi, A.2    Pui, C.H.3
  • 13
    • 0041526704 scopus 로고    scopus 로고
    • Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia
    • Morgan MA, Ganser A, Reuter CW. Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia. Leukemia 2003; 17: 1482-1498.
    • (2003) Leukemia , vol.17 , pp. 1482-1498
    • Morgan, M.A.1    Ganser, A.2    Reuter, C.W.3
  • 14
    • 0026555721 scopus 로고
    • Retroviral infection accelerates T lymphoma-genesis in e mu-N-ras transgenic mice by activating c-myc or N-myc
    • Haupt Y, Harris AW, Adams JM. Retroviral infection accelerates T lymphoma-genesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. Oncogene 1992; 7: 981-986.
    • (1992) Oncogene , vol.7 , pp. 981-986
    • Haupt, Y.1    Harris, A.W.2    Adams, J.M.3
  • 15
    • 78650651360 scopus 로고    scopus 로고
    • Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia
    • Wang J, Liu Y, Li Z, Du J, Ryu MJ, Taylor PR et al. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood 2010; 116: 5991-6002.
    • (2010) Blood , vol.116 , pp. 5991-6002
    • Wang, J.1    Liu, Y.2    Li, Z.3    Du, J.4    Ryu, M.J.5    Taylor, P.R.6
  • 16
    • 0033559734 scopus 로고    scopus 로고
    • Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice
    • MacKenzie KL, Dolnikov A, Millington M, Shounan Y, Symonds G. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood 1999; 93: 2043-2056.
    • (1999) Blood , vol.93 , pp. 2043-2056
    • MacKenzie, K.L.1    Dolnikov, A.2    Millington, M.3    Shounan, Y.4    Symonds, G.5
  • 17
    • 33749320394 scopus 로고    scopus 로고
    • Oncogenic NRAS rapidly and efficiently induces CMML-and AML-like diseases in mice
    • Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS rapidly and efficiently induces CMML-and AML-like diseases in mice. Blood 2006; 108: 2349-2357.
    • (2006) Blood , vol.108 , pp. 2349-2357
    • Parikh, C.1    Subrahmanyam, R.2    Ren, R.3
  • 18
    • 23044459131 scopus 로고    scopus 로고
    • Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse
    • Wiesner SM, Jones JM, Hasz DE, Largaespada DA. Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse. Blood 2005; 106: 1054-1062.
    • (2005) Blood , vol.106 , pp. 1054-1062
    • Wiesner, S.M.1    Jones, J.M.2    Hasz, D.E.3    Largaespada, D.A.4
  • 19
    • 0025234915 scopus 로고
    • Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens
    • Leenen PJ, Melis M, Slieker WA, Van Ewijk W. Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 1990; 20: 27-34.
    • (1990) Eur J Immunol , vol.20 , pp. 27-34
    • Leenen, P.J.1    Melis, M.2    Slieker, W.A.3    Van Ewijk, W.4
  • 20
    • 77954502166 scopus 로고    scopus 로고
    • The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice
    • Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, Wang Z et al. The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol 2010; 47: 434-445.
    • (2010) Vet Pathol , vol.47 , pp. 434-445
    • Hao, X.1    Fredrickson, T.N.2    Chattopadhyay, S.K.3    Han, W.4    Qi, C.F.5    Wang, Z.6
  • 21
    • 77349093317 scopus 로고    scopus 로고
    • Heterogeneity in a mouse model of histiocytosis: Transformation of Langerin + dendritic cells, macrophages, and precursors
    • Leenen PJ, Bechan GI, Melis M, den Broeder BJ, Lohler J, Egeler RM. Heterogeneity in a mouse model of histiocytosis: transformation of Langerin + dendritic cells, macrophages, and precursors. J Leukoc Biol 2010; 87: 949-958.
    • (2010) J Leukoc Biol , vol.87 , pp. 949-958
    • Leenen, P.J.1    Bechan, G.I.2    Melis, M.3    Den Broeder, B.J.4    Lohler, J.5    Egeler, R.M.6
  • 22
    • 0035985576 scopus 로고    scopus 로고
    • Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
    • Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
    • (2002) Histopathology , vol.41 , pp. 1-29
    • Pileri, S.A.1    Grogan, T.M.2    Harris, N.L.3    Banks, P.4    Campo, E.5    Chan, J.K.6
  • 23
    • 0030944985 scopus 로고    scopus 로고
    • Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
    • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
    • (1997) Cell , vol.88 , pp. 593-602
    • Serrano, M.1    Lin, A.W.2    McCurrach, M.E.3    Beach, D.4    Lowe, S.W.5
  • 24
    • 4644266046 scopus 로고    scopus 로고
    • Ha-Ras(G12V) induces senescence in primary and immortalized human esopha-geal keratinocytes with p53 dysfunction
    • Takaoka M, Harada H, Deramaudt TB, Oyama K, Andl CD, Johnstone CN et al. Ha-Ras(G12V) induces senescence in primary and immortalized human esopha-geal keratinocytes with p53 dysfunction. Oncogene 2004; 23: 6760-6768.
    • (2004) Oncogene , vol.23 , pp. 6760-6768
    • Takaoka, M.1    Harada, H.2    Deramaudt, T.B.3    Oyama, K.4    Andl, C.D.5    Johnstone, C.N.6
  • 25
    • 52949129499 scopus 로고    scopus 로고
    • Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
    • Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 2008; 14: 335-343.
    • (2008) Cancer Cell , vol.14 , pp. 335-343
    • Kotecha, N.1    Flores, N.J.2    Irish, J.M.3    Simonds, E.F.4    Sakai, D.S.5    Archambeault, S.6
  • 26
    • 42949122111 scopus 로고    scopus 로고
    • High EVI1 levels predict adverse outcome in acute myeloid leukemia: Prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
    • Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008; 111: 4329-4337.
    • (2008) Blood , vol.111 , pp. 4329-4337
    • Lugthart, S.1    Van Drunen, E.2    Van Norden, Y.3    Van Hoven, A.4    Erpelinck, C.A.5    Valk, P.J.6
  • 28
    • 27944449787 scopus 로고    scopus 로고
    • Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
    • Du Y, Jenkins NA, Copeland NG. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005; 106: 3932-3939.
    • (2005) Blood , vol.106 , pp. 3932-3939
    • Du, Y.1    Jenkins, N.A.2    Copeland, N.G.3
  • 29
    • 70449127230 scopus 로고    scopus 로고
    • Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors
    • Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919-1928.
    • (2009) Mol Ther , vol.17 , pp. 1919-1928
    • Modlich, U.1    Navarro, S.2    Zychlinski, D.3    Maetzig, T.4    Knoess, S.5    Brugman, M.H.6
  • 30
    • 79960261778 scopus 로고    scopus 로고
    • EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
    • De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K et al. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells. Br J Haematol 2011; 154: 337-348.
    • (2011) Br J Haematol , vol.154 , pp. 337-348
    • De Weer, A.1    Van Der Meulen, J.2    Rondou, P.3    Taghon, T.4    Konrad, T.A.5    De Preter, K.6
  • 31
    • 80053252121 scopus 로고    scopus 로고
    • Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis
    • Pradhan AK, Mohapatra AD, Nayak KB, Chakraborty S. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis. PLoS One 2011; 6: e25370.
    • (2011) PLoS One , vol.6
    • Pradhan, A.K.1    Mohapatra, A.D.2    Nayak, K.B.3    Chakraborty, S.4
  • 32
    • 33750624015 scopus 로고    scopus 로고
    • Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity
    • Modlich U, Bohne J, Schmidt M, von Kalle C, Knob S, Schambach A et al. Cell culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108: 2545-2553.
    • (2006) Blood , vol.108 , pp. 2545-2553
    • Modlich, U.1    Bohne, J.2    Schmidt, M.3    Von Kalle, C.4    Knob, S.5    Schambach, A.6
  • 34
    • 0036682167 scopus 로고    scopus 로고
    • The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
    • Diaz R, Ahn D, Lopez-Barcons L, Malumbres M, Perez de Castro I, Lue J et al. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res 2002; 62: 4514-4518.
    • (2002) Cancer Res , vol.62 , pp. 4514-4518
    • Diaz, R.1    Ahn, D.2    Lopez-Barcons, L.3    Malumbres, M.4    Perez De Castro, I.5    Lue, J.6
  • 36
    • 11944271042 scopus 로고
    • Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice
    • Mangues R, Seidman I, Gordon JW, Pellicer A. Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 1992; 7: 2073-2076.
    • (1992) Oncogene , vol.7 , pp. 2073-2076
    • Mangues, R.1    Seidman, I.2    Gordon, J.W.3    Pellicer, A.4
  • 37
    • 0028618377 scopus 로고
    • An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis
    • Mangues R, Kahn JM, Seidman I, Pellicer A. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Cancer Res 1994; 54: 6395-6401.
    • (1994) Cancer Res , vol.54 , pp. 6395-6401
    • Mangues, R.1    Kahn, J.M.2    Seidman, I.3    Pellicer, A.4
  • 38
    • 0029774270 scopus 로고    scopus 로고
    • Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumor-igenesis
    • Mangues R, Symmans WF, Lu S, Schwartz S, Pellicer A. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumor-igenesis. Oncogene 1996; 13: 1053-1063.
    • (1996) Oncogene , vol.13 , pp. 1053-1063
    • Mangues, R.1    Symmans, W.F.2    Lu, S.3    Schwartz, S.4    Pellicer, A.5
  • 39
    • 42249090881 scopus 로고    scopus 로고
    • Targeting Ras in myeloid leukemias
    • Braun BS, Shannon K. Targeting Ras in myeloid leukemias. Clin Cancer Res 2008; 14: 2249-2252.
    • (2008) Clin Cancer Res , vol.14 , pp. 2249-2252
    • Braun, B.S.1    Shannon, K.2
  • 41
    • 0027970795 scopus 로고
    • Histiocytes and histiocytosis
    • Cline MJ. Histiocytes and histiocytosis. Blood 1994; 84: 2840-2853.
    • (1994) Blood , vol.84 , pp. 2840-2853
    • Cline, M.J.1
  • 42
    • 0023640053 scopus 로고
    • Murine retrovirus-induced malignant histiocytosis, an experimental model for the disease in humans
    • Lohler J, Franz T, Fusco A, Pragnell I, Ostertag W. Murine retrovirus-induced malignant histiocytosis, an experimental model for the disease in humans. Leukemia 1987; 1: 58-68.
    • (1987) Leukemia , vol.1 , pp. 58-68
    • Lohler, J.1    Franz, T.2    Fusco, A.3    Pragnell, I.4    Ostertag, W.5
  • 44
    • 0028883813 scopus 로고
    • Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells
    • Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7547.
    • (1995) J Virol , vol.69 , pp. 7541-7547
    • Baum, C.1    Hegewisch-Becker, S.2    Eckert, H.G.3    Stocking, C.4    Ostertag, W.5
  • 45
    • 0036133070 scopus 로고    scopus 로고
    • In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity
    • Wahlers A, Zipfel PF, Schwieger M, Ostertag W, Baum C. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity. J Virol 2002; 76: 303-312.
    • (2002) J Virol , vol.76 , pp. 303-312
    • Wahlers, A.1    Zipfel, P.F.2    Schwieger, M.3    Ostertag, W.4    Baum, C.5
  • 46
    • 0036764776 scopus 로고    scopus 로고
    • Upstream conserved sequences of mouse leukemia viruses are important for high trans-gene expression in lymphoid and hematopoietic cells
    • Wahlers A, Kustikova O, Zipfel PF, Itoh K, Koester M, Heberlein C et al. Upstream conserved sequences of mouse leukemia viruses are important for high trans-gene expression in lymphoid and hematopoietic cells. Mol Ther 2002; 6: 313-320.
    • (2002) Mol Ther , vol.6 , pp. 313-320
    • Wahlers, A.1    Kustikova, O.2    Zipfel, P.F.3    Itoh, K.4    Koester, M.5    Heberlein, C.6
  • 47
    • 0036720398 scopus 로고    scopus 로고
    • The roles of FLT3 in hematopoiesis and leukemia
    • Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532-1542.
    • (2002) Blood , vol.100 , pp. 1532-1542
    • Gilliland, D.G.1    Griffin, J.D.2
  • 48
    • 79955814184 scopus 로고    scopus 로고
    • The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: A study in 39 cases of MDS or AML
    • Haferlach C, Bacher U, Haferlach T, Dicker F, Alpermann T, Kern W et al. The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. Leukemia 2011; 25: 874-877.
    • (2011) Leukemia , vol.25 , pp. 874-877
    • Haferlach, C.1    Bacher, U.2    Haferlach, T.3    Dicker, F.4    Alpermann, T.5    Kern, W.6
  • 49
    • 33646575624 scopus 로고    scopus 로고
    • Implications of NRAS mutations in AML: A study of 2502 patients
    • Bacher U, Haferlach T, Schoch C, Kern W, Schnittger S. Implications of NRAS mutations in AML: a study of 2502 patients. Blood 2006; 107: 3847-3853.
    • (2006) Blood , vol.107 , pp. 3847-3853
    • Bacher, U.1    Haferlach, T.2    Schoch, C.3    Kern, W.4    Schnittger, S.5
  • 50
    • 77956247735 scopus 로고    scopus 로고
    • Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia
    • Lugthart S, Groschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol 2010; 28: 3890-3898.
    • (2010) J Clin Oncol , vol.28 , pp. 3890-3898
    • Lugthart, S.1    Groschel, S.2    Beverloo, H.B.3    Kayser, S.4    Valk, P.J.5    Van Zelderen-Bhola, S.L.6
  • 51
    • 36849080028 scopus 로고    scopus 로고
    • Over-expression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
    • Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E, Tapinassi C et al. Over-expression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 2007; 117: 3696-3707.
    • (2007) J Clin Invest , vol.117 , pp. 3696-3707
    • Shing, D.C.1    Trubia, M.2    Marchesi, F.3    Radaelli, E.4    Belloni, E.5    Tapinassi, C.6
  • 52
    • 79951472496 scopus 로고    scopus 로고
    • Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
    • Li Q, Haigis KM, McDaniel A, Harding-Theobald E, Kogan SC, Akagi K et al. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Blood 2011; 117: 2022-2032.
    • (2011) Blood , vol.117 , pp. 2022-2032
    • Li, Q.1    Haigis, K.M.2    McDaniel, A.3    Harding-Theobald, E.4    Kogan, S.C.5    Akagi, K.6
  • 54
    • 34247391073 scopus 로고    scopus 로고
    • Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
    • Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, Kuwata T et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 2007; 109: 3998-4005.
    • (2007) Blood , vol.109 , pp. 3998-4005
    • Jin, G.1    Yamazaki, Y.2    Takuwa, M.3    Takahara, T.4    Kaneko, K.5    Kuwata, T.6
  • 55
    • 0842329808 scopus 로고    scopus 로고
    • Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice
    • Cuenco GM, Ren R. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Oncogene 2004; 23: 569-579.
    • (2004) Oncogene , vol.23 , pp. 569-579
    • Cuenco, G.M.1    Ren, R.2
  • 56
    • 21044448037 scopus 로고    scopus 로고
    • Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking
    • Kustikova O, Fehse B, Modlich U, Yang M, Dullmann J, Kamino K et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005; 308: 1171-1174.
    • (2005) Science , vol.308 , pp. 1171-1174
    • Kustikova, O.1    Fehse, B.2    Modlich, U.3    Yang, M.4    Dullmann, J.5    Kamino, K.6
  • 57
    • 49449084991 scopus 로고    scopus 로고
    • Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
    • Modlich U, Schambach A, Brugman MH, Wicke DC, Knoess S, Li Z et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008; 22: 1519-1528.
    • (2008) Leukemia , vol.22 , pp. 1519-1528
    • Modlich, U.1    Schambach, A.2    Brugman, M.H.3    Wicke, D.C.4    Knoess, S.5    Li, Z.6
  • 58
    • 25144490586 scopus 로고    scopus 로고
    • Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells
    • Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 2005; 106: 2530-2533.
    • (2005) Blood , vol.106 , pp. 2530-2533
    • Calmels, B.1    Ferguson, C.2    Laukkanen, M.O.3    Adler, R.4    Faulhaber, M.5    Kim, H.J.6
  • 61
    • 80053629212 scopus 로고    scopus 로고
    • Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia
    • Vazquez I, Maicas M, Cervera J, Agirre X, Marin-Bejar O, Marcotegui N et al. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Haematologica 2011; 96: 1448-1456.
    • (2011) Haematologica , vol.96 , pp. 1448-1456
    • Vazquez, I.1    Maicas, M.2    Cervera, J.3    Agirre, X.4    Marin-Bejar, O.5    Marcotegui, N.6
  • 62
    • 70349640956 scopus 로고    scopus 로고
    • Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
    • Konrad TA, Karger A, Hackl H, Schwarzinger I, Herbacek I, Wieser R. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol 2009; 86: 813-822.
    • (2009) J Leukoc Biol , vol.86 , pp. 813-822
    • Konrad, T.A.1    Karger, A.2    Hackl, H.3    Schwarzinger, I.4    Herbacek, I.5    Wieser, R.6
  • 63
    • 37549065049 scopus 로고    scopus 로고
    • BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia
    • Omidvar N, Kogan S, Beurlet S, le Pogam C, Janin A, West R et al. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res 2007; 67: 11657-11667.
    • (2007) Cancer Res , vol.67 , pp. 11657-11667
    • Omidvar, N.1    Kogan, S.2    Beurlet, S.3    Le Pogam, C.4    Janin, A.5    West, R.6
  • 64
    • 33750023988 scopus 로고    scopus 로고
    • Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
    • Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 2006; 13: 1524-1533.
    • (2006) Gene Ther , vol.13 , pp. 1524-1533
    • Schambach, A.1    Mueller, D.2    Galla, M.3    Verstegen, M.M.4    Wagemaker, G.5    Loew, R.6
  • 65
    • 0032520260 scopus 로고    scopus 로고
    • Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic rogenitors
    • Meyer J, Jucker M, Ostertag W, Stocking C. Carboxyl-truncated STAT5beta is generated by a nucleus-associated serine protease in early hematopoietic rogenitors. Blood 1998; 91: 1901-1908.
    • (1998) Blood , vol.91 , pp. 1901-1908
    • Meyer, J.1    Jucker, M.2    Ostertag, W.3    Stocking, C.4
  • 66
    • 0034915569 scopus 로고    scopus 로고
    • Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples
    • Schmidt M, Hoffmann G, Wissler M, Lemke N, Mussig A, Glimm H et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 2001; 12: 743-749.
    • (2001) Hum Gene Ther , vol.12 , pp. 743-749
    • Schmidt, M.1    Hoffmann, G.2    Wissler, M.3    Lemke, N.4    Mussig, A.5    Glimm, H.6
  • 67
    • 60749091879 scopus 로고    scopus 로고
    • Retroviral insertion site analysis in dominant haematopoietic clones
    • Kustikova OS, Modlich U, Fehse B. Retroviral insertion site analysis in dominant haematopoietic clones. Methods Mol Biol 2009; 506: 373-390.
    • (2009) Methods Mol Biol , vol.506 , pp. 373-390
    • Kustikova, O.S.1    Modlich, U.2    Fehse, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.